TOP 10: Biotech stocks being bought and sold by billionaires right now

By Admin
Biotech and health care stocks continue to be some of the most popular to watch, and the wave of consolidations in the health and pharma space is attrac...

Biotech and health care stocks continue to be some of the most popular to watch, and the wave of consolidations in the health and pharma space is attracting top hedge fund billionaires.

Forbes recently compiled a list of the 20 biotech and health care stocks the richest hedge fund billionaires are looking at based on the number of billionaires who either bought or sold the stock in at least 10,000 shares.

RELATED TOPIC: 3 stocks to watch in the US medical marijuana market

The year 2015 saw a sharp increase in the number of M&A deals, and the events shifted the interest in certain stocks. The anticipation of more deals to come drew “votes of confidence” for targets such as Teva Pharmaceutical. Actavis, however, is on both the top selling and buying list as hedge fund billionaires can’t seem to agree with the most widely held stock among U.S. hedge funds.

Top stocks being bought
1. Actavis
2. Curis  
3. Endo International
4. Teva Pharmaceutical
5. Boston Scientific

 

Actavis is 24 percent owned by hedge funds. The debate on whether to buy or sell this stock stems from the merger between the Dublin-based drug giant and Botox maker Allergan.

RELATED TOPIC: The 3 most expensive pharmaceutical mergers and acquisitions

Top stocks being sold
1. HCA Holdings
2. Abbvie
3. Actavis
4. Medtronic
5. Shire

 

HCA Holdings comes at No. 1 on Forbes’ list, as nine hedge fund billionaires cut back their positions at the end of Q1 after the hospital operator’s positive stock return over the past year. The stock, however, jumped 9 percent in June as the Supreme Court ruled to uphold an important part of the Affordable Care Act, benefitting hospital operations.  

RELATED TOPIC: Anthem to become largest US health insurer after $54B Cigna acquisition

To see the complete list, visit Forbes

Let's connect!   

Read the latest edition of Healthcare Global magazine!

Share

Featured Articles

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

McKinsey report reveals cost inflation is forcing AMCs to find operational efficiencies, or face cutting back on crucial training & education programmes

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance

McKinsey: ‘Women’s Healthcare Neglected for Decades'

Digital Healthcare